SCV

Sands Capital Ventures Portfolio holdings

AUM $508M
This Quarter Return
-21.07%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
10 Year Return
AUM
$364M
AUM Growth
+$364M
Cap. Flow
+$14M
Cap. Flow %
3.85%
Top 10 Hldgs %
90.27%
Holding
19
New
1
Increased
1
Reduced
1
Closed

Sector Composition

1 Healthcare 43.47%
2 Technology 28.23%
3 Consumer Discretionary 10.6%
4 Financials 9.38%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PATH icon
1
UiPath
PATH
$5.95B
$69.3M 19.04%
3,811,779
DICE
2
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$48.9M 13.42%
3,148,970
DASH icon
3
DoorDash
DASH
$105B
$38.6M 10.6%
601,454
NU icon
4
Nu Holdings
NU
$71.5B
$34.2M 9.38%
9,136,835
SNOW icon
5
Snowflake
SNOW
$79.6B
$29.8M 8.2%
214,621
KRTX
6
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$21.9M 6.01%
172,895
-95,000
-35% -$12M
TXG icon
7
10x Genomics
TXG
$1.74B
$21.8M 5.99%
+481,770
New +$21.8M
CINC
8
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$17.9M 4.91%
950,000
ABOS icon
9
Acumen Pharmaceuticals
ABOS
$82.4M
$16.1M 4.41%
3,417,075
OLK
10
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$10.7M 2.94%
705,514
+280,000
+66% +$4.26M
MASS icon
11
908 Devices
MASS
$226M
$6.72M 1.85%
326,427
TARS icon
12
Tarsus Pharmaceuticals
TARS
$2.47B
$3.8M 1.04%
260,000
RGEN icon
13
Repligen
RGEN
$6.88B
$3.66M 1.01%
22,544
IOT icon
14
Samsara
IOT
$20.6B
$3.64M 1%
326,000
TSHA icon
15
Taysha Gene Therapies
TSHA
$797M
$2.7M 0.74%
724,873
CADL icon
16
Candel Therapeutics
CADL
$318M
$2.63M 0.72%
811,737
SPRB
17
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
$1.37M 0.38%
787,007
ABSI icon
18
Absci
ABSI
$357M
$192K 0.05%
57,804